India

DengiAll: ICMR & Panacea Biotec Initiate First Indigenous Dengue Vaccine Phase 3 Clinical Trial

By
OB Bureau

New Delhi: The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec. The first participant in this trial was vaccinated at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, according to a PIB release.

Commenting on this milestone, Union Minister of Health & Family Welfare, Shri J.P. Nadda, said, “The initiation of this Phase 3 clinical trial for India’s first indigenous dengue vaccine marks a critical advancement in our fight against dengue. It reflects our commitment to protecting our citizens from this pervasive disease and underscores India’s capabilities in vaccine research and development. Through this collaboration between ICMR and Panacea Biotec, we are not only taking a step towards ensuring the health and well-being of our people but also reinforcing our vision of Atmanirbhar Bharat in the healthcare sector.”

Currently, there is no antiviral treatment or licensed vaccine against dengue in India. The development of an effective vaccine is complex due to the need to achieve good efficacy for all four serotypes. All four serotypes of Dengue virus are known to circulate or co-circulate in many regions in India.

The tetravalent dengue vaccine strain (TV003/TV005), originally developed by the National Institutes of Health (NIH), USA, has shown promising results in preclinical and clinical trials worldwide. Panacea Biotec, one of three Indian companies to receive the strain, is at the most advanced stage of development. The company has worked extensively on these strains to develop a full-fledged vaccine formulation and holds a process patent for this work. Phase 1 and 2 clinical trials of the Indian vaccine formulation were completed in 2018-19, yielding promising results.

In collaboration with ICMR, Panacea Biotec will conduct the Phase 3 clinical trial across 19 sites in 18 states and Union Territories of India, involving more than 10,335 healthy adult participants. The trial, primarily funded by ICMR with partial support from Panacea Biotec, is set to follow up with participants for two years. This initiative represents a significant step towards developing an indigenous vaccine for one of India’s most pressing public health challenges and exemplifies the nation’s commitment to Atmanirbhar Bharat.

 

OB Bureau

Recent Posts

Payal Rohatgi Calls Out Rupali Ganguly For Dating A Married Man

Mumbai: Actress Rupali Ganguly recently filed a Rs 50 crore defamation case against her stepdaughter…

November 14, 2024

National Hockey: Odisha To Clash With Manipur In Semifinals

Chennai: Odisha will face Manipur in the semifinals of the 14th Hockey India Senior Men’s…

November 14, 2024

India To Push Canada For Extradition Of Arrested Khalistani Terrorist Arsh Dalla

New Delhi: India will again ask Canada for the extradition of designated Khalistani terrorist Arshdeep Singh…

November 14, 2024

School Dropout From West Bengal Arrested For Practising As Ayurvedic Doctor In Odisha’s Berhampur

Berhampur: Police have arrested a man from West Bengal for allegedly claiming himself to be…

November 14, 2024

Manoj Bajpayee Recalls Staying In ‘Hell’, Experiencing Starvation

Mumbai: Carving a niche for himself in Bollywood was not a cakewalk for ‘The Family…

November 14, 2024

After Disapproving Of Ranveer, Mukesh Khanna Rejects Tiger Shroff For ‘Shakitmaan’

Mumbai: Mukesh Khanna’s Indian superhero series ‘Shaktimaan’ has been making headlines for quite some time…

November 14, 2024

2nd Tigress Arrives In Odisha’s Similipal Tiger Reserve From Maharashtra

Bhubaneswar: As part of Odisha government's tiger relocation project, second tigress from Maharashtra arrived at…

November 14, 2024

Severe Pollution: Central Panel Forced To Invoke GRAP 3 In Delhi From Tomorrow

New Delhi: Hours after Delhi’s Environment Minister Gopal Rai said that the third phase of…

November 14, 2024